title: Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches.
abstract: In several epithelial malignancies, detection of circulating tumor cells (CTCs) in the peripheral blood has diagnostic, prognostic, and therapeutic implications. However, the clinical relevance of CTCs in esophageal squamous cell carcinoma (ESCC) has not yet been ascertained. The study was conducted with the aim of determining the clinical significance of CTCs in patients with ESCC by using 2 CTC detection systems, one epithelial marker-dependent and the other epithelial marker-independent. Paired peripheral blood samples were prospectively obtained from 61 ESCC patients before treatment and were analyzed for CTCs isolated by the CellSearch system (CS) and the method of isolation by size of epithelial tumor (ISET). Blood samples from 22 healthy volunteers were used as controls. Out of 61 study subjects, CTCs were detected in 20 patients (32.8%) by the ISET method and in only 1 patient (1.6%) by the CS method. Circulating tumor microemboli (CTM) were observed in 3 of 61 (4.9%) patients using ISET, but were undetectable in any of the patient by CS method. No CTCs/CTM were detected by either method in control groups. By ISET method, the presence of CTCs appeared to correlate with the stage of ESCC and with the baseline median platelet levels. No correlation with any other relevant clinicopathological variables was observed. Our results clearly indicate the ability of both CS and ISET methods to detect CTCs in peripheral blood samples from ESCC patients. However, the CellSearch system appears to have a poorer sensitivity as compared with the ISET method. Further studies are essential for assessing the role of such technologies in ESCC.
authors.affiliation: From the Department of Interventional Radiology (HL), Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong; Shandong Cancer Hospital and Institute (HL), Jinan, Shandong; Department of Thoracic Surgery (PS, BZ), Shandong Cancer Hospital and Institute, Jinan, Shandong; Department of Urology (BZ), Shandong Cancer Hospital and Institute, Jinan, Shandong; Department of Clinical Laboratory (ML), Shandong Cancer Hospital and Institute, Jinan, Shandong; Department of Hepatobiliary Surgery (KC, SL), Shandong Cancer Hospital and Institute, Jinan, Shandong; Wuhan YZY Medical Science & Technology Co. Ltd (PZ), Wuhan, Hubei; and Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders (SL), Qingdao University, Qingdao, Shandong, China.
authors.forename: Hao
authors.initials: H
authors.lastname: Li
authors.forename: Pingping
authors.initials: P
authors.lastname: Song
authors.forename: Benkui
authors.initials: B
authors.lastname: Zou
authors.forename: Min
authors.initials: M
authors.lastname: Liu
authors.forename: Kai
authors.initials: K
authors.lastname: Cui
authors.forename: Pengfei
authors.initials: P
authors.lastname: Zhou
authors.forename: Sheng
authors.initials: S
authors.lastname: Li
authors.forename: Baijiang
authors.initials: B
authors.lastname: Zhang
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis*; D002294:Carcinoma, Squamous Cell / Q000097:blood* / Q000473:pathology; D016022:Case-Control Studies; D002469:Cell Separation / Q000379:methods*; D004938:Esophageal Neoplasms / Q000097:blood* / Q000473:pathology; D004947:Esophagus / Q000473:pathology; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D008297:Male; D008875:Middle Aged; D009360:Neoplastic Cells, Circulating
chemical_list: D014408:Biomarkers, Tumor